Life sciences: commercial real estate in Lyon (France)
The Lyon-Gerland Biopole
The Gerland biopole or how to encourage innovation, business creation and setting up.
Lyonbiopole is the epicentre of the world competitiveness cluster in infectology, the Gerland quarter is home to:
- world leaders in human and animal health - Genzyme, Merial, Sanofi-Pasteur etc,
- large numbers of SMEs and start-ups,
- several research centres, including the P4 laboratory, and higher education establishments such as Lyon ENS, ISARA and the university of Lyon 1,
all supported by the main research organisations including the CNRS, the INRA, the INRIA as well as the INSERM.
Fertile ground for innovative new companies
In this very stimulating environment, young innovative businesses are finding fertile ground for development:
- cutting edge research in the Life Sciences,
- recognised expertise from molecular biology to virology not to mention bioinformatics,
- collaboration between organisations that is stimulated by the quality of the available resources as well as the scope of the technology:
- diagnostic testing platform technology,
- availability of services from the Lyon Bioinformatics Centre (PBIL).
Solutions tailored to the needs of new organizations
The biopole provides tailored solutions for new organisations at various stages of development.
A wide range of properties
- 400 m2 of business-incubator space for start-ups at ENS Lyon and the IBCP,
- 8,500 m2 of start-up and post-start-up premises, made available by Greater Lyon (Châteaubriand and Tony Garnier) and Lyonbiopole (Lyonbiopole Business Centre, acCInov, Infectiology Centre).
An ambitious development plan
- The Charles Mérieux Campus, will offer all disciplines on the Gerland site the means to pursue quality research in close cooperation with the Biosciences as part of the National Campus Plan.
- Lyon Techsud, is a development area, with facilities ranging from the service sector to manufacturing and including laboratories, which aims to develop business activities to find common ground with the scientific and industrial world of the Lyon Gerland Biopole. Lyon Techsud is the last possible developmen area of such as size dedicated to the economic development in the Lyon area.
- The Infectology Centre, with facilities developed by Lyonbiopole with the financial support of Greater Lyon (CPER) offers 1,920 m2 of laboratories, providing space for 84 people over in 7 fully-equipped units, common areas, including a P3 platform as well as some shared elements. Lyonbiopole has made its expertise available to the teams it houses; they benefit from advice from the Governance of Lyonbiopole and its technical Group.
- acCInov "ACellerating the operational functioning of the Infectology Centre to better inNOVate", is a new part of the ongoing work of the Infectology Centre, with a new building, a sort of "hotel for technical platforms" that occupies 6,000 m2 and will house SMEs and start-ups who will supply services in the areas of biological analysis and/or bioproduction.
- Institute for Technological Research (IRT) will materialise at the heart of the Gerland biopole in a new 30,000 m2 complex that will house Lyonbiopole's teams and technical areas.
Tony Garnier
This Science and Technical Business Centre is managed by the SERL.
The building offers 3,300 m2 of space for premises of which 1,000 m2 are an incubator for young innovative businesses.
The occupants benefit from shared space and services.
At the end of 2011 (figures from May 2011) the building housed 12 businesses and had a 98% occupancy rate.
Chateaubriand
This building, managed by Greater Lyon is designed to be a scientific and technical centre for business.
The building has 2,650 m2 of space and houses:
- 5 businesses in the Life Sciences ICT sector who have taken 2,400 m2 of space,
- The Gerland organisation itself occupies the remaining 250 m2.
East Lyon Health Complex
With an exceptional location at the heart of the Lyon metropolitan area, the East Lyon Health Complex is a strategic site for biomedical training and research and is one of the most concentrated scientific, hospital and training centres in Europe:
- Ten or so public and private hospitals, 2/3 of beds in the Lyon conurbation
- 1,100 researchers
- 15 INSERM (National Institute for Health and Medical Research) facilities
- most of the employees of the 3 Research and Care Networks (Synergie Lyon Cancer, Neurodis and the Centaure Foundation)
- 10,000 students
- The Rhône-Alpes Auvergne Cancer hub (CLARA)
- the International Centre for Cancer Research (CIRC)
3 areas of excellence
The development strategy of the East Lyon Health Complex is targeted towards three areas of excellence:
- oncology with the presence, in particular, of the Edouard Herriot Hospital, the Léon Bérard Centre and the WHO IARC project which plans to set up the National Hadron Therapy Centre for the treatment of cancer, one of only 5 of this type of facility in the world (Etoile Centre)
- neuroscience (CPER Neurocampus project, 7 mixed research units (UMRs) at the IFR19, CERMEP, IDEE foundation)
- Cardiovascular Disease (Louis Pradel cardiovascular and pneumonia hospital, the CIC INSERM-Hospices Civils de Lyon )
- transplants (transplant medicine department INSERM 503, transplant surgery department UMR MA 103, 4 pivotal teams in the transplant research network, Centaure Foundation)
The Laennec Start-up Park
BIOPARC portal reserved for young businesses in the biomedical sector; this business incubator offers:
- 1,140 m2 for office space and areas that can be set aside for laboratories.
The occupants benefit from shared space and services.
By the end of 2011 it was housing 11 BIO or ICT businesses as well as the CLARA cancer hub and had a 100% occupancy rate.
Lyon Bioparc
LYON BIOPARC ® : the Life Sciences at the heart of the city
Objectives of Lyon Bioparc ®
BIOPARC LYON a city site dedicated to the Life Sciences is situated at the heart of the East Lyon Health Complex has as its objective to house R&D facilities which will benefit from the close proximity of:
- research centres such as the Léon Bérard anti-cancer centre and the International Centre for Research into Cancer (WHO-CIRC) and also
- over 6,000 hospital beds (general medicine, neurology, gynaecology/obstetrics and paediatrics, cardiology and oncology).
In the long term, LYON BIOPARC has been designed to provide over 40,000 m2 of office and laboratory space in a 4 hectare area, which represents huge potential for development and partnership for all Life Science businesses.
A real-estate solution for all
LYON BIOPARC offers real-estate solutions to meet everyone's needs the leasing or purchase of flexible space that can be adapted to meet the needs of laboratories and start-ups. It also features the Laënnec start-up park, which provides accommodation for new businesses in the sector.
A first building office and laboratory building, with 6 floors, opened in August 2007 and is already home to some 15 companies that have set up there (ADENINE building)
Lyon bioparc is a project with an international reach that will greatly strengthen Lyon's reputation in biotechnology.
News
- Erytech Pharma: success of the initial public offering, raising EUR 17.7 million in April 2013 (23/05/13)
- Biovision 2013: world most prominent life sciences experts expected at the world life sciences forum in Lyon (22/03/13)
- Biovision 2013: Biovision Investor Conference, 330 million euro cumulative fund raising by the 35 selected companies (22/03/13)
Project call
Related files
- Accinov : communiqué de presse de la pose de la 1re pierre du 5 juillet 2012 (PDF - 152 Ko)
- Accinov : dossier de presse de la plateforme d'innovation du 5 juillet 2012 (PDF - 1.6 Mo)
- CLARA: progress report 2010 (french version) (PDF - 8.5 Mo)
- CLARA: progress report 2010 (PDF - 6.4 Mo)
- Lyon Gerland : dossier de presse "présentation des projets du Biopôle" du 25 mars 2013 (PDF - 4.1 Mo)













